Growth hormone receptor could serve as possible target for improving lung cancer treatment

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Loti Labs Advances GHRP-6 Research and Studies With Precision Peptides

Loti Labs produces GHRP-6 peptides to research-grade specifications, ensuring they meet the exact composition required for controlled and repeatable experimental outcomes. Each batch is meticulously ...
WebMD

Treating Growth Hormone Deficiency With Skytrofa

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...
USA Today

What does growth hormone therapy treat? What an endocrinologist needs you to know.

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...
WebMD

Does Human Growth Hormone Affect Alzheimer's Risk?

Recent research findings put a spotlight on the link between human growth hormone (HGH) and Alzheimer’s disease. Could taking HGH increase your risk of Alzheimer’s? Ultimately, scientists say they ...

FDA approves Novo Nordisk's Sogroya(R) as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
Medscape

FDA Okays New Indications for Once-Weekly Growth Hormone

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.